Studi Kasus Pasien Dengan Meningitis Tuberkulosis Dalam Pengobatan Tuberkulosis Paru

Authors

  • Riduan Benny Nahampun RSUD Tarutung
  • Helny Tarigan Puskesmas Juhar

DOI:

https://doi.org/10.61132/vitamin.v2i2.216

Keywords:

loss of conscioucness, tuberculous meningitis, management

Abstract

TB meningitis is the most severe manifestation of tuberculosis infection and causes death and disability in 50% of sufferers. Tuberculosis primarily affects adults at their most productive ages. However, all age groups remain at risk. Tuberculous meningitis is a form of extra-pulmonary tuberculosis with neurological abnormalities that accounts for 70-80% of all neurological tuberculosis cases, 5.2% of all extrapulmonary tuberculosis and 0.7% of all tuberculosis cases. Tuberculous meningitis (TB) is preceded by prodromal symptoms such as headache, anorexia, nausea/vomiting, subfebrile fever, accompanied by behavioural changes, and decreased consciousness. The patient, a 42-year-old male Mr SM, presented with decreased consciousness, a history of seizures and was taking tuberculosis drugs. Meningeal stimulation was found to be rigid, laseque test and kernique test were positive. Motor system impression of lateralisation to the right. Laboratory examination showed leukocytes 13,500/uL, platelets 728,000/uL, sodium 123 mmol, Kgd 135, thoracic X-ray with the impression of pulmonary tuberculosis with pneumonia, cranial CT-scan obtained with the impression of appropriate Tb meningitis, Non Communicating hydrocephalus. Specific treatments given were IVFD NaCL 0.9 %  20 drops / m, Omeprazole vial 2x40 mg, paracetamol infusion 3x1000 mg, Ceftriaxone 1 gram Vial, dexamethason ampoule loading 2 ampoules then 3x5 mg, Phenytoin 3x100 mg, Levofloxacin 750 mg, rifampicin 1x450 mg, isoniazid 1x300 mg, pyrazinamide 1x1000 mg, ethambutol 1x1000 mg, mg, B6 and B12 2x1 tablets.

References

Tiara Aninditha, Salim Haris,Winnugroho. Neuroinfeksi: Buku Ajar Neurologi Edisi kedua.2022; 1039

World Health Organization. Global tuberculosis USA: World Health Organization; 2022 Tersedia: http://www.who.int/indonesia/news/campaign/tb-day-2022

Chin JH. Tuberculous Meningitis: Diagnostic and theurapeutic challenges. Neurology Clin Prac. 2014; 4(3):199-205.

Thamrin APY. Pria 31 tahun dengan suspek meningitis tuberkulosis dan AIDS. MEDULA. 2015; 4(1):1-7.

Thwaites GE, Bhavnani SM, Chau TT, Hammel JP, Torok ME, Van Wart SA, et al. Randomized pharmacokinetic and pharmacodynamic comparison of fluoroquinolones for tuberculous meningitis. Antimicrob Agents Chemother. 2011; 55(7):3244-53.

Perhimpunan Dokter Spesialis Saraf Indoneisa. Standar Pelayanan Medik. Jakarta: Perdossi; 2013.

Perhimpunan Dokter Paru Indonesia. Tuberkulosis pedoman diagnosis dan penatalaksanaan di Indonesia. Jakarta: PDPI; 2006.

Downloads

Published

2024-02-05

How to Cite

Riduan Benny Nahampun, & Helny Tarigan. (2024). Studi Kasus Pasien Dengan Meningitis Tuberkulosis Dalam Pengobatan Tuberkulosis Paru. Vitamin : Jurnal Ilmu Kesehatan Umum, 2(2), 01–09. https://doi.org/10.61132/vitamin.v2i2.216

Similar Articles

1 2 > >> 

You may also start an advanced similarity search for this article.